Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 34(12): 1449-52, 2014 Dec.
Artigo em Chinês | MEDLINE | ID: mdl-25632744

RESUMO

OBJECTIVE: To study the effect of Zhibai Dihuang Pill (ZBDHP) on urokinase-type plasminogen activator (uPA) and sperm quality in ureaplasma urealyticum (Uu) infection infertile patients. METHODS: Recruited were 80 infertility patients with Uu infection at Andriatrics Clinics and Department of Reproduction, including 130 cases of positive Uu semen and 50 cases of negative Uu semen. Patients with positive Uu semen were randomly assigned to the observation group (72 cases) and the control group (58 cases) according to the visit sequence. All patients took antibiotics for 2 weeks. Patients in the observation group additionally took ZBDHP, 6 g each time, twice daily. Those in the control group additionally took Vit E (100 mg each time, twice per day) and ATP (40 mg each time, twice per day). The therapeutic course for all was 90 days. Semen parameters and uPA contents of the sperm membrane were detected and comparatively analyzed. RESULTS: The sperm membrane uPA content, the sperm motility, the sperm viability, and the percentage of normal morphology sperm in Uu positive infected patients were lower than those in Uu negative infected patients with statistical difference (P < 0.05), but with no significant difference in the sperm density between the two groups (P > 0.05). There was no statistical difference in pre-treatment sperm membrane uPA contents and sperm parameters between the two groups (P > 0.05). Compared with before treatment in the same group, the sperm membrane uPA content, the sperm motility, the sperm viability, and the percentage of normal morphology sperm obviously increased in the two groups with statistical difference (P < 0.05). After treatment, the sperm membrane uPA content increased more obviously in the observation group, with statistical difference when compared with the control group (P < 0.05). CONCLUSIONS: Infection with Uu leads to decreased uPA content of sperm membrance and the sperm motility. ZBDHP could effectively treat Uu infected infertility possibly through fighting against Uu damaged sperm membrane and make the sperm membrane uPA content return to normal, and elevate the fertilizability of sperms.


Assuntos
Antibacterianos/farmacologia , Medicamentos de Ervas Chinesas/farmacologia , Infecções por Ureaplasma/tratamento farmacológico , Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Doenças Transmissíveis , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/uso terapêutico , Humanos , Infertilidade , Infertilidade Masculina , Masculino , Sêmen , Análise do Sêmen , Contagem de Espermatozoides , Motilidade dos Espermatozoides , Espermatozoides , Ureaplasma urealyticum/efeitos dos fármacos
2.
Zhong Yao Cai ; 32(2): 235-9, 2009 Feb.
Artigo em Chinês | MEDLINE | ID: mdl-19504969

RESUMO

OBJECTIVE: To investigate the inhibitory effects of Pomegranate peel extracts (PPE) on experimental prostatitis rats. METHODS: The Prostatitis model was established by injection of carrageenan and Staphylococcus aureus in rat prostate. After 9 days' treatments of PPE, the rats were sacrificed for measurement of the number of white blood cell (WBC), the density of lecithin, the levels of Zn and malondialdehyde (MDA) of prostate. The antioxidant capacity was measured by oxygen radical absorbance capacity (ORAC) assay. The levels of NO and the activity of acid phosphatase (ACP) of plasma were also measured. RESULTS: PPE increased the levels of ORAC in plasma and the density of lecithin and the levels of Zn, decreased the levels of MDA of prostate and the activity of ACP and the number of WBC and adjusted the levels of NO in plasma compared with the prostatitis model group (P < 0.05 or P < 0.01). CONCLUSION: PPE can markedly improve the protective function of oxidation resistance, it may involve its regulatory action on anti-oxidation.


Assuntos
Antioxidantes/farmacologia , Lythraceae/química , Extratos Vegetais/farmacologia , Próstata/metabolismo , Prostatite/patologia , Alanina Transaminase/sangue , Animais , Antioxidantes/administração & dosagem , Modelos Animais de Doenças , Frutas/química , Masculino , Malondialdeído/metabolismo , Óxido Nítrico/sangue , Oxirredução , Extratos Vegetais/administração & dosagem , Extratos Vegetais/isolamento & purificação , Próstata/efeitos dos fármacos , Próstata/patologia , Prostatite/metabolismo , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Zinco/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA